{"id":950628,"date":"2026-04-13T01:05:12","date_gmt":"2026-04-13T05:05:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/"},"modified":"2026-04-13T01:05:12","modified_gmt":"2026-04-13T05:05:12","slug":"innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/","title":{"rendered":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026"},"content":{"rendered":"

<\/p>\n

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026<\/b><\/p>\n

MARSEILLE, France–(BUSINESS WIRE<\/a>)–
\nRegulatory News:<\/p>\n

\nInnate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate<\/b>\u201d or the \u201cCompany<\/b>\u201d) will hold its Annual General Meeting of shareholders (\u201cAGM<\/b>\u201d) at 10:30 a.m. CEST on May 21, 2026, at its headquarters, 117 avenue de Luminy, 13009 Marseille.<\/p>\n

\nThe notice of meeting for this AGM was published on April 13, 2026 in the French Bulletin des annonces l\u00e9gales obligatoires (BALO). It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM.<\/p>\n

\nDocuments and information relating to the AGM will be made available to shareholders in compliance with current regulations on the Investors section<\/a> of the Company’s website.<\/p>\n

\nThe AGM will also be broadcast live and accessible at the following link: Innate Pharma 2026 Annual General Meeting<\/a><\/p>\n

\nA guided tour of the Company’s laboratories will be organized on the same day at 9:15 a.m. CEST for shareholders. Shareholders can register for the tour via the following link: registration form<\/a>.<\/p>\n

Further information regarding the AGM:<\/b><\/p>\n

\nOnly shareholders who have registered their shares in an account at least five trading business days prior to the date of the AGM, i.e. May 14, 2026, at 00:00 (Paris time), will be entitled to attend the General Meeting.<\/p>\n

\nShareholders holding \u201cau porteur<\/i>\u201d (bearer) shares will need to obtain an \u201cattestation de participation<\/i>\u201d (certificate of shareholding) from their brokers. This \u201cattestation de participation<\/i>\u201d must be attached to the voting or proxy form.<\/p>\n

\nWritten questions from shareholders must be received no later than four business days prior to the AGM, i.e. May 15, 2026, at the following address: investors@innate-pharma.fr<\/a>.<\/p>\n

\nShareholders can also obtain the documents and information relating to the AGM (as described in Article R. 225-83 of the French Commercial Code) by sending a request by e-mail to investors@innate-pharma.fr<\/a>.<\/p>\n

About Innate Pharma<\/b><\/p>\n

\nInnate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Leveraging its expertise on antibody-engineering and innovative target identification, Innate Pharma is developing innovative and differentiated next-generation antibody therapeutics.<\/p>\n

\nInnate Pharma is advancing a portfolio of differentiated potential first and\/or best-in-class assets, focused on areas of high unmet medical need, including IPH4502, a differentiated Nectin-4 ADC developed in solid tumors, lacutamab, an anti-KIR3DL2 antibody developed in cutaneous T cell lymphomas and peripheral T cell lymphomas, and monalizumab, an anti-NKG2A antibody developed in collaboration with AstraZeneca in non-small cell lung cancer.<\/p>\n

\nInnate Pharma has established collaborations with leading biopharmaceutical companies, including Sanofi and AstraZeneca, as well as renowned academic and research institutions, to advance innovation in immuno-oncology.<\/p>\n

\nHeadquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.<\/p>\n

\nLearn more about Innate Pharma at www.innate-pharma.com<\/a>. Follow us on LinkedIn<\/a> and X<\/a>.<\/p>\n

Information about Innate Pharma shares<\/b><\/p>\n\n\n
\n

ISIN code
\n<\/b>
Ticker code
\n<\/b>
LEI<\/b><\/p>\n<\/td>\n

\n

\nFR0010331421<\/p>\n

\nEuronext: IPH Nasdaq: IPHA<\/p>\n

\n9695002Y8420ZB8HJE29<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

Disclaimer on forward-looking information and risk factors<\/b><\/p>\n

\nFor a discussion of risks and uncertainties, please refer to the Risk Factors (\u201cFacteurs de Risque”) section of the Universal Registration Document filed with the French Financial Markets Authority (\u201cAMF\u201d), which is available on the AMF website http:\/\/www.amf-france.org<\/a> or on Innate Pharma\u2019s website (www.innate-pharma.com<\/a>), and public filings and reports filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d), including the Company\u2019s Annual Report on Form 20-F for the year ended December 31, 2025, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public by the Company. References to the Company\u2019s website and the AMF website are included for information only and the content contained therein, or that can be accessed through them, are not incorporated by reference into, and do not constitute a part of, this press release.<\/p>\n

\nThis press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260412530712\/en\/<\/a><\/span><\/p>\n

Investors & Media Relations
\n<\/span><\/b>
Innate Pharma<\/b><\/p>\n

\nSt\u00e9phanie Cornen
\n
stephanie.cornen@innate-pharma.fr<\/a><\/p>\n

Investor Relations
\n<\/b>
investors@innate-pharma.fr<\/a><\/p>\n

Media
\n<\/b>
communication@innate-pharma.fr<\/a><\/p>\n

KEYWORDS:<\/b> Europe United States North America France<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 MARSEILLE, France–(BUSINESS WIRE)– Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its Annual General Meeting of shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 21, 2026, at its headquarters, 117 avenue de Luminy, 13009 Marseille. The notice of meeting for this AGM was published on April 13, 2026 in the French Bulletin des annonces l\u00e9gales obligatoires (BALO). It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. Documents and information relating to the AGM will be made available to shareholders in compliance with current regulations on the Investors section of … <\/p>\n

Continue reading “Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950628","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nInnate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 MARSEILLE, France–(BUSINESS WIRE)– Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its Annual General Meeting of shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 21, 2026, at its headquarters, 117 avenue de Luminy, 13009 Marseille. The notice of meeting for this AGM was published on April 13, 2026 in the French Bulletin des annonces l\u00e9gales obligatoires (BALO). It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. Documents and information relating to the AGM will be made available to shareholders in compliance with current regulations on the Investors section of … Continue reading "Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-13T05:05:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026\",\"datePublished\":\"2026-04-13T05:05:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/\"},\"wordCount\":729,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/\",\"name\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-04-13T05:05:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/","og_locale":"en_US","og_type":"article","og_title":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Market Newsdesk","og_description":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 MARSEILLE, France–(BUSINESS WIRE)– Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its Annual General Meeting of shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 21, 2026, at its headquarters, 117 avenue de Luminy, 13009 Marseille. The notice of meeting for this AGM was published on April 13, 2026 in the French Bulletin des annonces l\u00e9gales obligatoires (BALO). It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. Documents and information relating to the AGM will be made available to shareholders in compliance with current regulations on the Investors section of … Continue reading \"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-13T05:05:12+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026","datePublished":"2026-04-13T05:05:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/"},"wordCount":729,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/","name":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-04-13T05:05:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260412530712r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950628"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950628\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}